pounds 100m innovations council to bring medtech to centre stage in UK
This article was originally published in Clinica
Executive Summary
Innovations, the much-touted key to greater reliance on technologies, is major element in blueprint for the development of the UK's NHS over the next ten years. A host of UK healthcare bodies and industry associatios broadly welcomed the interim report our NHS, our future, but there is no hiding the special tone of some of their responses.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.